ENGN
enGene Therapeutics Inc.Company with tickers: ENGN, ENGNW
CIK
1980845
CUSIP
29286M105
Shares Outstanding
66,989,466
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-01-30 | Giguere Lee | Chief Legal Ofc. and Corp Secy | Award | 195,000 |
| 2026-01-30 | Nichols Alexander Julian | Chief Strategy & Ops. Ofc | Award | 195,000 |
| 2026-01-30 | Buck Jill | EVP, GM Gene Therapy | Award | 195,000 |
| 2026-01-30 | Connolly Joan | Chief Technology Officer | Award | 195,000 |
| 2026-01-30 | Boyd Matthew Ross | Chief Regulatory Officer | Award | 195,000 |
| 2026-01-30 | CHEUNG ANTHONY TZEYEW | Chief Scientific Officer | Award | 195,000 |
| 2026-01-30 | Daws D. Ryan | Chief Financial Officer | Award | 220,000 |
| 2026-01-30 | Cooper Ronald Harold Wilfred | Director, CEO & President | Award | 801,000 |
| 2025-09-30 | Sweiti Hussein | Chief Medical Officer | Award | 600,000 |
| 2025-09-29 | Sweiti Hussein | Chief Medical Officer | Other | 0 |
| 2025-07-08 | Grossman William | Director | Award | 45,000 |
| 2025-07-08 | Buck Jill | EVP, GM Gene Therapy | Award | 100,000 |
| 2025-07-08 | Heffernan Michael Thomas | Director | Award | 45,000 |
| 2025-07-08 | Boyd Matthew Ross | Chief Regulatory Officer | Award | 100,000 |
| 2025-07-08 | Astley-Sparke Philip | Director | Award | 45,000 |
| 2025-07-08 | Astley-Sparke Philip | Director | Other | 20,000 |
| 2025-07-08 | Buck Jill | EVP, GM Gene Therapy | Other | 0 |
| 2025-07-08 | Buck Jill | EVP, GM Gene Therapy | Other | 0 |
| 2025-07-08 | Boyd Matthew Ross | Chief Regulatory Officer | Other | 7,500 |
| 2025-07-08 | Boyd Matthew Ross | Chief Regulatory Officer | Other | 0 |
| 2025-07-08 | Boyd Matthew Ross | Chief Regulatory Officer | Other | 0 |
| 2025-07-08 | Heffernan Michael Thomas | Director | Other | 0 |
| 2025-07-08 | Grossman William | Director | Other | 0 |
| 2025-06-16 | Glickman Richard M | Director | Award | 22,500 |
| 2025-06-16 | BRUNK GERALD A | Director | Award | 22,500 |
| 2025-06-16 | Bos Jasper | Director | Award | 22,500 |
| 2025-06-16 | Zoth Lota S. | Director | Award | 22,500 |
| 2025-06-16 | Pott Amy | Director | Award | 400,000 |
| 2025-06-16 | Joustra Wouter | Director | Award | 22,500 |
| 2025-06-16 | HASTINGS PAUL J | Director | Award | 22,500 |
| 2025-05-27 | Pott Amy | Director | Other | 0 |
| 2025-01-29 | Nichols Alexander Julian | Chief Strategy & Ops. Ofc | Award | 250,000 |
| 2025-01-29 | Giguere Lee | Chief Legal Ofc. and Corp Secy | Award | 250,000 |
| 2025-01-29 | Daws D. Ryan | Chief Financial Officer | Award | 280,000 |
| 2025-01-29 | CHEUNG ANTHONY TZEYEW | Chief Scientific Officer | Award | 250,000 |
| 2025-01-29 | Pruthi Raj Som | Chief Medical Officer | Award | 280,000 |
| 2025-01-29 | Cooper Ronald Harold Wilfred | Director, CEO & President | Award | 850,000 |
| 2024-10-30 | Forbion Growth Opportunities Fund I Cooperatief U.A. | 10% Owner | Buy | 561,797 |
| 2024-10-30 | Forbion Growth Opportunities Fund I Cooperatief U.A. | 10% Owner | Other | 3,765,932 |
| 2024-10-21 | CHEUNG ANTHONY TZEYEW | Chief Scientific Officer | Award | 100,000 |
| 2024-10-21 | Connolly Joan | Chief Technology Officer | Award | 210,000 |
| 2024-10-21 | Connolly Joan | Chief Technology Officer | Other | 0 |
| 2024-10-08 | Forbion Growth Opportunities Fund I Cooperatief U.A. | 10% Owner | Buy | 800 |
| 2024-10-07 | Forbion Growth Opportunities Fund I Cooperatief U.A. | 10% Owner | Buy | 11,844 |
| 2024-10-04 | Forbion Growth Opportunities Fund I Cooperatief U.A. | 10% Owner | Buy | 5,997 |
| 2024-10-03 | Forbion Growth Opportunities Fund I Cooperatief U.A. | 10% Owner | Buy | 5,769 |
| 2024-10-02 | Forbion Growth Opportunities Fund I Cooperatief U.A. | 10% Owner | Buy | 10,153 |
| 2024-10-01 | Forbion Growth Opportunities Fund I Cooperatief U.A. | 10% Owner | Buy | 35,279 |
| 2024-09-30 | Forbion Growth Opportunities Fund I Cooperatief U.A. | 10% Owner | Buy | 341,332 |
| 2024-09-27 | Forbion Growth Opportunities Fund I Cooperatief U.A. | 10% Owner | Buy | 38,396 |
| 2024-09-27 | Forbion Growth Opportunities Fund I Cooperatief U.A. | 10% Owner | Buy | 3,243 |
| 2024-09-27 | Cooper Ronald Harold Wilfred | Director, CEO & President | Buy | 10,000 |
| 2024-07-24 | Pruthi Raj Som | Chief Medical Officer | Award | 110,000 |
| 2024-07-22 | Cooper Ronald Harold Wilfred | Director, CEO & President | Award | 1,250,000 |
| 2024-07-22 | Pruthi Raj Som | Chief Medical Officer | Other | 0 |
| 2024-07-22 | Cooper Ronald Harold Wilfred | Director, CEO & President | Other | 0 |
| 2024-06-15 | Joustra Wouter | Director | Award | 40,000 |
| 2024-06-15 | Glickman Richard M | Director | Award | 20,000 |
| 2024-06-15 | BRUNK GERALD A | Director | Award | 20,000 |
| 2024-06-15 | Zoth Lota S. | Director | Award | 20,000 |
| 2024-06-15 | HASTINGS PAUL J | Director | Award | 40,000 |
| 2024-06-15 | Bos Jasper | Director | Award | 20,000 |
| 2024-05-28 | Glickman Richard M | Director | Convert | 120 |
| 2024-05-28 | Glickman Richard M | Director | Convert | 120 |
| 2024-05-15 | Joustra Wouter | Director | Other | 0 |
| 2024-05-15 | HASTINGS PAUL J | Director | Other | 0 |
| 2024-04-22 | FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC | 10% Owner | Sell | 47,854 |
| 2024-04-19 | FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC | 10% Owner | Sell | 100 |
| 2024-04-18 | FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC | 10% Owner | Sell | 4,575 |
| 2024-03-21 | Zoth Lota S. | Director | Award | 40,000 |
| 2024-03-18 | CHEUNG ANTHONY TZEYEW | Chief Scientific Officer | Convert | 52,940 |
| 2024-03-18 | CHEUNG ANTHONY TZEYEW | Chief Scientific Officer | Convert | 52,940 |
| 2024-03-15 | Giguere Lee | Chief Legal Ofc. and Corp Secy | Award | 225,000 |
| 2024-02-20 | BRUNK GERALD A | Director | Award | 155,035 |
| 2024-02-20 | BRUNK GERALD A | Director | Other | 1,077,386 |
| 2024-02-20 | BRUNK GERALD A | Director | Award | 644,965 |
| 2024-02-20 | BRUNK GERALD A | Director | Other | 1,341,790 |
| 2024-02-20 | BRUNK GERALD A | Director | Other | 152,974 |
| 2024-02-20 | BRUNK GERALD A | Director | Other | 44,647 |
| 2024-02-20 | Lumira Capital Investment Management Inc. | 10% Owner | Other | 152,974 |
| 2024-02-20 | Lumira Capital Investment Management Inc. | 10% Owner | Other | 1,341,790 |
| 2024-02-20 | Lumira Capital Investment Management Inc. | 10% Owner | Other | 1,077,386 |
| 2024-02-20 | Lumira Capital Investment Management Inc. | 10% Owner | Award | 644,965 |
| 2024-02-20 | Lumira Capital Investment Management Inc. | 10% Owner | Other | 44,647 |
| 2024-02-20 | Lumira Capital Investment Management Inc. | 10% Owner | Award | 155,035 |
| 2024-01-29 | Giguere Lee | Chief Legal Ofc. and Corp Secy | Other | 0 |
| 2023-12-29 | Forbion Growth Opportunities Fund I Cooperatief U.A. | 10% Owner | Buy | 9,620 |
| 2023-12-29 | Forbion Growth Opportunities Fund I Cooperatief U.A. | 10% Owner | Buy | 400 |
| 2023-12-28 | Forbion Growth Opportunities Fund I Cooperatief U.A. | 10% Owner | Buy | 5,050 |
| 2023-12-27 | Forbion Growth Opportunities Fund I Cooperatief U.A. | 10% Owner | Other | 3,765,932 |
| 2023-12-27 | Forbion Growth Opportunities Fund I Cooperatief U.A. | 10% Owner | Buy | 2,750 |
| 2023-12-18 | Zoth Lota S. | Director | Other | 0 |
| 2023-11-30 | BRYCE RICHARD PAUL | SEE REMARKS | Award | 153,000 |
| 2023-11-30 | Daws D. Ryan | Chief Financial Officer | Award | 232,000 |
| 2023-11-27 | Daws D. Ryan | Chief Financial Officer | Other | 0 |
| 2023-10-31 | CHEUNG ANTHONY TZEYEW | Chief Scientific Officer | Award | 49,933 |
| 2023-10-31 | Lumira Capital Investment Management Inc. | 10% Owner | Other | 83,816 |
| 2023-10-31 | Lumira Capital Investment Management Inc. | 10% Owner | Other | 0 |
| 2023-10-31 | Lumira Capital Investment Management Inc. | 10% Owner | Other | 0 |
| 2023-10-31 | Lumira Capital Investment Management Inc. | 10% Owner | Other | 0 |